share_log

HC Wainwright & Co. Maintains Buy on Caribou Biosciences, Raises Price Target to $24

Moomoo 24/7 ·  Mar 19 06:26

HC Wainwright & Co. analyst Robert Burns maintains Caribou Biosciences (NASDAQ:CRBU) with a Buy and raises the price target from $23 to $24.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment